Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
deCODE genetics: Variants in the genome affect DNA methylation 2024-07-24 17:00
For the First time in Thailand! Chulalongkorn University Researchers Found a "Glowing Land Snail" 2024-07-24 16:46
Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services 2024-07-24 12:30
IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis 2024-07-24 09:52
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent 2024-07-24 08:10
Telix Successfully Prices A$650 Million Convertible Bonds 2024-07-24 07:51
ViewMind Applauded by Frost & Sullivan for Revolutionizing Brain Health Assessment and Care with Its Ocular Digital Phenotyping Solution 2024-07-23 21:00
Telix Announces A$600 Million Convertible Bonds Offering 2024-07-23 16:35
SND Introduces Revolutionary Moderated Drinking Treatment Program 2024-07-23 16:29
Linical Named Best Global CRO by Global Health & Pharma Magazine 2024-07-23 09:00
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs 2024-07-23 08:00
DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease 2024-07-23 08:00
Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million 2024-07-23 01:23
Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program 2024-07-22 21:00
Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency 2024-07-22 19:48
Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial 2024-07-22 19:00
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit 2024-07-22 09:12
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors 2024-07-22 08:00
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
1 43 44 45 46 47 962